Skip to content

Study of the Adequacy Between Calcium Supplementation and Dietary Intake in Treatment-naive Patients After a Fracture

Study of the Adequacy Between Calcium Supplementation and Dietary Intake in Treatment-naive Patients After Fracture With a Fracture Suspected of Being Due to Bone Insufficiency, Consulting a Rheumatologist for the First Time in at Least 5 Years.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06847087
Acronym
MONTE-CRIST'OS
Enrollment
86
Registered
2025-02-26
Start date
2025-04-03
Completion date
2026-01-29
Last updated
2026-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis, Post-Traumatic, Calcium Supplementation, Osteoporosis, Management Care, Fracture

Brief summary

Osteoporosis is a disease that causes many fractures. However, treatments exist such as anti-osteoporotic treatments, vitamin D supplementation and an adaptation of calcium intake. 80% of patients with an indication for anti-osteoporotic treatment are never treated with these anti-osteoporotic treatments after a first fracture. On the other hand, more than 84% of them are supplemented with calcium and vitamin D. It often appears in the practice of rheumatologists that some patients are supplemented while their dietary intake is sufficient, and vice versa. The objective of the study is therefore to take stock of the (in)adequacy between the dietary intake of patients and the supplementation prescribed to them following an osteoporotic-like fracture.

Interventions

Assessment of the inadequacy between dietary and medicinal calcium intake by the Fardellone self-questionnaire and the patient's clinical record

Sponsors

Centre Hospitalier de Colmar
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient meeting a first rheumatologist after a fracture suspected of being due to bone insufficiency, whether or not he is already treated for osteoporosis * Age ≥ 18 years * Patient followed in one of the three investigation centers within the framework of the bone sector. * Patient affiliated to a social security system

Exclusion criteria

* Patient refusing to participate in the study * Patient already followed by a rheumatologist * Legal incapacity or any physical, psychological, social or geographical condition likely to hinder the patient's ability to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Number of patients deficient, within the norm and above the norm with or without supplementationDay 1percentage of patients

Secondary

MeasureTime frameDescription
Previously performed bone densitometryDay 1Results of densitormetry by a T score
Prevalence of a history of fractureDay 1Number of bone fractures the patient has already had before inclusion
First indication for the initiation of anti-osteoporotic treatment.Day 1Date of the first indication for the initiation of an anti-osteoporotic treatment. This date is appearing in the medical record
Duration without treatment before a fracture occursDay 1Duration without treatment before a fracture occurs and type of the treatment
Number of participants who need for readjustment by the rheumatologist after inclusionDay 1Implementation of educational measures by the rheumatologist in the event of inadequacy and optimization of anti-osteoporotic treatments

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026